Successful Treatment of Neuropathic Pain and Mood Symptoms with Duloxetine in a Patient with West Nile Virus Infection

Authors

  • Ian M. Fowler Department of Anesthesia and Pain Medicine, Naval Medical Center, San Diego, San Diego, California 92134, USA
  • Ross A. Gliniecki Department of Anesthesia and Pain Medicine, Naval Medical Center, San Diego, San Diego, California 92134, USA
  • Lauren H. Mattingly Primary Care Clinic, Naval Branch Health Clinic Fort Worth, Fort Worth, Texas 76127, USA

DOI:

https://doi.org/10.14205/2310-9394.2015.03.02.5

Keywords:

Neuropathic pain, virus infection.

Abstract

Neuropathic pain and concomitant mood disorder in West Nile Virus (WNV) infection seem difficult to control. A 57years old female diagnosed with neuroinvasive WNV infection presented with burning pain in the hands and feet consistent with neuropathic pain. In addition, a Patient Health Questionnaire-2 (PHQ-2) depression screening questionnaire administered to her was positive and on further interview she met diagnostic criteria for a mood disorder due to a general medical condition. Her symptoms included a loss of pleasure in all activities and mood lability. During her course of treatment, she also underwent five months of intensive physical therapy for rehabilitation and received intravenous immunoglobulin infusions for flaccid paralysis secondary to an inflammatory peripheral neuropathy attributed to WNV infection. The neuropathic pain and mood disorder dramatically disappeared after using duloxetine. Duloxetine is recommended for neuropathic pain management especially in patients with WNV infection.

References

Burton J, Kern R, Halliday W, Mikulis D, Brunton J, et al. Neurological manifestations of West Nile Virus infection. Can J Neurol Sci 2004; 31: 185-193.

Petersen L, Brault A, Nasci R. West Nile Virus: Review of the literature. JAMA 2013; 310: 308-315. http://dx.doi.org/10.1001/jama.2013.8042

Lavoie-Smith E, Pang H, Cirrincione C, Fleishman S, Paskett E, et al. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA 2013; 309: 1359-1367. http://dx.doi.org/10.1001/jama.2013.2813

Sumner N, Jones L. Multifocal neuropathy associated with West Nile Virus infection. Neurology 2008; 71: 1123. http://dx.doi.org/10.1212/01.wnl.0000326964.26673.8e

Doron S, Dasche J, Adelman L, et al. Histopathologically proven poliomyelitis with quadriplegia and loss of brainstem function due to West Nile Virus. Clin Infect Dis 2003; 37: 374- 377. http://dx.doi.org/10.1086/377177

Sejvar J, Leis A, Stokic D, Van Gerpen J, Marfin A, et al. Acute flaccid paralysis and West Nile Virus infection. Emerg Infect Dis 2003; 9: 788-793. http://dx.doi.org/10.3201/eid0907.030129

Leis A, Stokic D, Webb R, Slavinski S, Fratkin J. Clinical spectrum of muscle weakness in human West Nile Virus infection. Muscle Nerve 2003; 28: 302-308. http://dx.doi.org/10.1002/mus.10440

Sejvar JJ, Bode AV, Marfin AA, Campbell G, Pape J, et al. West Nile Virus associated flaccid paralysis. Emerg Infect Dis 2005; 11: 1021-1027. http://dx.doi.org/10.3201/eid1107.040991

Cheeran M, Hu S, Sheng W, Rashid A, Peterson P, et al. Differential responses of human brain cells to West Nile Virus infection. J Neurovirol 2005; 11: 512-524. http://dx.doi.org/10.1080/13550280500384982

Glass EG, Lim JK, Cholera R, Pletnev A, Gao J, et al. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile Virus infection. J Exp Med 2005; 202: 1087-1098. http://dx.doi.org/10.1084/jem.20042530

Thacker M, Clark A, Marchand F, McMahon S. Pathophysiology of peripheral neuropathic pain: Immune cells and molecules. Anesth Analg 2007; 105: 838-847. http://dx.doi.org/10.1213/01.ane.0000275190.42912.37

Sadek JR, Pergam SA, Harrington JA, Echevarria L, Davis L, et al. Persistent neuropsychological impairment associated with West Nile Virus infection. J Clin Exp Neuropsychol 2010; 32: 81-87. http://dx.doi.org/10.1080/13803390902881918

Jensen MP, Chodroff MJ, Dworkin RH. The impact of neuropathic pain on health-related quality of life. Neurology 2007; 68: 1178-1182. http://dx.doi.org/10.1212/01.wnl.0000259085.61898.9e

Haaland KY, Sadek J, Pergam S, Echevarria LA, Davis LE, et al. Mental status after West Nile virus infection. Emerg Infect Dis 2006; 12: 1260-1262. http://dx.doi.org/10.3201/eid1708.060097

Murray KO, Resnick M, Miller V. Depression after infection with West Nile virus. Emerg Infect Dis 2007; 13: 479-481. http://dx.doi.org/10.3201/eid1303.060602

Klee AL, Maldin B, Edwin B, Poshni I, Mostashari F, et al. Long-term prognosis for clinical West Nile virus infection. Emerg Infect Dis 2004; 10: 1405-1411. http://dx.doi.org/10.3201/eid1008.030879

Lima L, Drujan B, Walder R. Cerebral serotonin in viral encephalitis. J Neural Trasm Suppl 1990; 29: 141-151. http://dx.doi.org/10.1007/978-3-7091-9050-0_14

Russell IJ, Mease PJ, Smith TR, Kajdasz DK, Wholreich MM, et al. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain 2008; 136: 432-444. http://dx.doi.org/10.1016/j.pain.2008.02.024

Wang SY, Calderon J, Kuo Wang G. Block of neuronal Na+ channels by antidepressant duloxetine in a state-dependent manner. Anesthesiology 2010; 113: 655-665. http://dx.doi.org/10.1097/aln.0b013e3181e89a93

Martinez-Lavin M, Solan C. Dorsal root ganglia, sodium channels, and fibromyalgia sympathetic pain. Med Hypotheses 2009; 72: 64-66. http://dx.doi.org/10.1016/j.mehy.2008.07.055

Downloads

Published

2015-12-31

Issue

Section

Articles